Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - CAPRICOR THERAPEUTICS, INC. | tm2014566d1_10q.htm |
| EX-32.2 - EXHIBIT 32.2 - CAPRICOR THERAPEUTICS, INC. | tm2014566d1_ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - CAPRICOR THERAPEUTICS, INC. | tm2014566d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - CAPRICOR THERAPEUTICS, INC. | tm2014566d1_ex31-1.htm |
| EX-4.2 - EXHIBIT 4.2 - CAPRICOR THERAPEUTICS, INC. | tm2014566d1_ex4-2.htm |
| EX-4.1 - EXHIBIT 4.1 - CAPRICOR THERAPEUTICS, INC. | tm2014566d1_ex4-1.htm |
Exhibit 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Linda Marbán, Ph.D., the Principal Executive Officer of Capricor Therapeutics, Inc. (the “Company”), hereby certifies, to her knowledge, that:
(1) the Quarterly Report on Form 10-Q of the Company for the period ended March 31, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the period covered by the Report.
Date: May 15, 2020
| /s/ Linda Marbán, Ph.D. | |
| Name: Linda Marbán, Ph.D. | |
| Title: Chief Executive Officer and Principal Executive Officer |